{"id":"https://openalex.org/W2080126574","doi":"https://doi.org/10.1038/clpt.1994.6","title":"Quinidine-enhanced \u03b2-blockade during treatment with propafenone in extensive metabolizer human subjects","display_name":"Quinidine-enhanced \u03b2-blockade during treatment with propafenone in extensive metabolizer human subjects","publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W2080126574","doi":"https://doi.org/10.1038/clpt.1994.6","mag":"2080126574","pmid":"https://pubmed.ncbi.nlm.nih.gov/7905369"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.1994.6","doi":"https://doi.org/10.1038/clpt.1994.6","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.1994.6","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109192873","display_name":"Klaus M\u00f6rike","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Klaus E M\u00f6rike","raw_affiliation_strings":["Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN 37232-6602","Division of Clinical Pharmacology Vanderbilt University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN 37232-6602","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Division of Clinical Pharmacology Vanderbilt University","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058141203","display_name":"Dan M. Roden","orcid":"https://orcid.org/0000-0002-6302-0389","observed_orcids":["https://orcid.org/0000-0002-6302-0389"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dan M Roden","raw_affiliation_strings":["Division of Clinical Pharmacology, Vanderbilt University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5058141203"],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.5603,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.89303905,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"55","issue":"1","first_page":"28","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/propafenone","display_name":"propafenone","score":0.8650000095367432},{"id":"https://openalex.org/keywords/quinidine","display_name":"quinidine","score":0.996999979019165},{"id":"https://openalex.org/keywords/beta-adrenergic-blockade","display_name":"beta-adrenergic blockade","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.8169999718666077},{"id":"https://openalex.org/keywords/extensive-metabolizers","display_name":"extensive metabolizers","score":0.890999972820282},{"id":"https://openalex.org/keywords/poor-metabolizers","display_name":"poor metabolizers","score":0.8669999837875366},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5789999961853027},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.6480000019073486},{"id":"https://openalex.org/keywords/heart-rate-response-to-exercise","display_name":"heart rate response to exercise","score":0.9419999718666077},{"id":"https://openalex.org/keywords/antiarrhythmic-drugs","display_name":"antiarrhythmic drugs","score":0.8059999942779541},{"id":"https://openalex.org/keywords/sodium-channel-blockers","display_name":"sodium channel blockers","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C2781472538","wikidata":"https://www.wikidata.org/wiki/Q662511","display_name":"Propafenone","level":3,"score":0.9387274980545044},{"id":"https://openalex.org/C2780339425","wikidata":"https://www.wikidata.org/wiki/Q412496","display_name":"Quinidine","level":2,"score":0.9013352990150452},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6047917604446411},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49953603744506836},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4853293001651764},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32458633184432983},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05972084403038025},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.05787244439125061}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D007545","descriptor_name":"Isoproterenol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011405","descriptor_name":"Propafenone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011405","descriptor_name":"Propafenone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011405","descriptor_name":"Propafenone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011802","descriptor_name":"Quinidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011802","descriptor_name":"Quinidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015444","descriptor_name":"Exercise","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/clpt.1994.6","doi":"https://doi.org/10.1038/clpt.1994.6","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.1994.6","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:7905369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7905369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G120018185","display_name":null,"funder_award_id":"GM31304","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G1611452204","display_name":null,"funder_award_id":"RR-095","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G7982882065","display_name":"DETERMINANTS  OF INDIVIDUAL RESPONSIVENESS TO DRUGS","funder_award_id":"P01GM031304","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1992426863","https://openalex.org/W2052847179","https://openalex.org/W2003020809","https://openalex.org/W2014643868","https://openalex.org/W2263983966","https://openalex.org/W2031176987","https://openalex.org/W2035668176","https://openalex.org/W2350759191","https://openalex.org/W4241243003","https://openalex.org/W1986443718"],"abstract_inverted_index":{"Propafenone,":[0],"a":[1,89,110,147],"sodium":[2],"channel":[3],"blocking":[4],"antiarrhythmic":[5],"drug":[6,137,144],"with":[7],"beta-blocking":[8],"properties,":[9],"is":[10,39],"metabolized":[11],"to":[12,119],"non-beta-blocking":[13],"metabolites":[14],"in":[15,30,34,53,88,112,129,141],"part":[16],"by":[17,109,117],"cytochrome":[18],"P4502D6.":[19],"Subtherapeutic":[20],"doses":[21],"of":[22,99,105,136],"quinidine":[23,49,73,100,125],"inhibit":[24],"P4502D6":[25],"and":[26,60,116],"increase":[27],"plasma":[28],"propafenone":[29,65,82],"extensive":[31,54,59,95,130],"metabolizer":[32],"subjects,":[33],"whom":[35],"the":[36,46,97,103,133],"active":[37],"enzyme":[38],"present.":[40],"In":[41,94],"this":[42],"study":[43],"we":[44],"tested":[45],"hypothesis":[47],"that":[48,123],"would":[50],"enhance":[51],"beta-blockade":[52,128],"metabolizers":[55,63],"receiving":[56],"propafenone.":[57],"Seven":[58],"two":[61],"poor":[62],"received":[64],"(225":[66],"mg":[67,76],"orally":[68,77],"every":[69,78],"8":[70,79],"hours)":[71,80],"plus":[72,83],"sulfate":[74],"(60":[75],"or":[81],"placebo":[84],"for":[85],"7":[86],"days":[87],"randomized,":[90],"double-blind,":[91],"crossover":[92],"fashion.":[93],"metabolizers,":[96],"coadministration":[98],"significantly":[101],"increased":[102],"extent":[104],"propafenone-induced":[106,127],"beta-blockade,":[107],"assessed":[108],"decrease":[111],"exercise":[113],"heart":[114],"rate":[115],"sensitivity":[118],"isoproterenol.":[120],"We":[121],"conclude":[122],"low-dose":[124],"enhances":[126],"metabolizers.":[131],"Thus":[132],"polymorphic":[134],"patterns":[135],"metabolism":[138],"can":[139],"result":[140],"clinically":[142],"significant":[143],"interactions":[145],"on":[146],"genetic":[148],"basis.":[149]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}